chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fatigue, Feeling hot, Hypotension, Pyrexia
Clinical narrative: Narrative: Presented to ER on 8/1/21 with low blood pressure concerns over 48 hours. Reported warmth and chills. Fever confirmed in ER. Noted patient was in in ER 3x earlier that week for other concerns not related to COVID infection. Dx with COVID Pneumonia. Admitted as in-patient and symptoms evolved to include fatigue, weakness, SOB, chest congestion, and cough. Treated with IV Remdesivir (08/02 - 08/06) and IV Dexamethasone 6 mg IV x 1 dose then po daily to complete 10 day course. Supportive care included ascorbic acid, zinc ,benzonatate, albuterol and supplemental O2. Discharged 8/6 with oral dexamethasone (tx end date: 8/2/21). Co-morbid conditions include HTN, BPH, T2DM,psoriasis (on apremilast), hx non-small cell lung cancer s/p chemo + radiation, gout, hyperlipidemia, obesity, non-obstructive renal calculi (right hydronephrosis s/p ureteral stent)
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative: Presented to ER on 8/1/21 with low blood pressure concerns over 48 hours. Reported warmth and chills. Fever confirmed in ER. Noted patient was in in ER 3x earlier that week for other concerns not related to COVID infection. Dx with COVID Pneumonia. Admitted as in-patient and symptoms evolved to include fatigue, weakness, SOB, chest congestion, and cough. Treated with IV Remdesivir (08/02 - 08/06) and IV Dexamethasone 6 mg IV x 1 dose then po daily to complete 10 day course. Supportive care included ascorbic acid, zinc ,benzonatate, albuterol and supplemental O2. Discharged 8/6 with oral dexamethasone (tx end date: 8/2/21). Co-morbid conditions include HTN, BPH, T2DM,psoriasis (on apremilast), hx non-small cell lung cancer s/p chemo + radiation, gout, hyperlipidemia, obesity, non-obstructive renal calculi (right hydronephrosis s/p ureteral stent)
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Angiogram pulmonary abnormal, Aspartate aminotransferase increased, Blood creatine phosphokinase increased, Blood creatinine increased
Clinical narrative: Narrative: 66 y/o male with Hx of obesity, DM2, HLD and 2 out of 2 COVID vaccination who presents with fever, cough, fatigue. The patient states that he recently has been exposed to his granddaughter who tested positive on Aug 16th. Since that time the patient states he developed symptoms such as fever, dry cough, congestion, diarrhea, headache. In the next few days he himself tested positive outside the Facility on Aug 18th. He tried to quarantine at home but symptoms worsened and therefore presented to the ED. COVID positive. HR 85, BP 105/80, RR 18, On 3L nasal cannula. Labs showed, BUN 26, Cr 1.22, AST 97, ALT 71, CBC/INR normal, Trop neg, BNP normal. CPK 448, CRP 147, Procal 1.41, Ferritin >2000, LDH 538. Ddimer 1.21. CTA: negative for PE, moderate GGO's in bilateral lungs consistent for COVID pneumonia. He was admitted to the medicine service. HOSPITAL COURSE: The patient was admitted to the hospitalist service. Covid pneumonia with hypoxemia - Patient treated with course of dexamethasone/remdesevir. The patient did require supplemental oxygen (1-2L) for a few days but this was stopped several days prior to discharge. Discharged to home.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactate dehydrogenase increased, Blood urea increased, Brain natriuretic peptide normal, C-reactive protein increased, COVID-19
Clinical narrative: Narrative: 66 y/o male with Hx of obesity, DM2, HLD and 2 out of 2 COVID vaccination who presents with fever, cough, fatigue. The patient states that he recently has been exposed to his granddaughter who tested positive on Aug 16th. Since that time the patient states he developed symptoms such as fever, dry cough, congestion, diarrhea, headache. In the next few days he himself tested positive outside the Facility on Aug 18th. He tried to quarantine at home but symptoms worsened and therefore presented to the ED. COVID positive. HR 85, BP 105/80, RR 18, On 3L nasal cannula. Labs showed, BUN 26, Cr 1.22, AST 97, ALT 71, CBC/INR normal, Trop neg, BNP normal. CPK 448, CRP 147, Procal 1.41, Ferritin >2000, LDH 538. Ddimer 1.21. CTA: negative for PE, moderate GGO's in bilateral lungs consistent for COVID pneumonia. He was admitted to the medicine service. HOSPITAL COURSE: The patient was admitted to the hospitalist service. Covid pneumonia with hypoxemia - Patient treated with course of dexamethasone/remdesevir. The patient did require supplemental oxygen (1-2L) for a few days but this was stopped several days prior to discharge. Discharged to home.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cough, Diarrhoea, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Narrative: 66 y/o male with Hx of obesity, DM2, HLD and 2 out of 2 COVID vaccination who presents with fever, cough, fatigue. The patient states that he recently has been exposed to his granddaughter who tested positive on Aug 16th. Since that time the patient states he developed symptoms such as fever, dry cough, congestion, diarrhea, headache. In the next few days he himself tested positive outside the Facility on Aug 18th. He tried to quarantine at home but symptoms worsened and therefore presented to the ED. COVID positive. HR 85, BP 105/80, RR 18, On 3L nasal cannula. Labs showed, BUN 26, Cr 1.22, AST 97, ALT 71, CBC/INR normal, Trop neg, BNP normal. CPK 448, CRP 147, Procal 1.41, Ferritin >2000, LDH 538. Ddimer 1.21. CTA: negative for PE, moderate GGO's in bilateral lungs consistent for COVID pneumonia. He was admitted to the medicine service. HOSPITAL COURSE: The patient was admitted to the hospitalist service. Covid pneumonia with hypoxemia - Patient treated with course of dexamethasone/remdesevir. The patient did require supplemental oxygen (1-2L) for a few days but this was stopped several days prior to discharge. Discharged to home.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer, Full blood count normal, Headache, Hypoxia, International normalised ratio normal
Clinical narrative: Narrative: 66 y/o male with Hx of obesity, DM2, HLD and 2 out of 2 COVID vaccination who presents with fever, cough, fatigue. The patient states that he recently has been exposed to his granddaughter who tested positive on Aug 16th. Since that time the patient states he developed symptoms such as fever, dry cough, congestion, diarrhea, headache. In the next few days he himself tested positive outside the Facility on Aug 18th. He tried to quarantine at home but symptoms worsened and therefore presented to the ED. COVID positive. HR 85, BP 105/80, RR 18, On 3L nasal cannula. Labs showed, BUN 26, Cr 1.22, AST 97, ALT 71, CBC/INR normal, Trop neg, BNP normal. CPK 448, CRP 147, Procal 1.41, Ferritin >2000, LDH 538. Ddimer 1.21. CTA: negative for PE, moderate GGO's in bilateral lungs consistent for COVID pneumonia. He was admitted to the medicine service. HOSPITAL COURSE: The patient was admitted to the hospitalist service. Covid pneumonia with hypoxemia - Patient treated with course of dexamethasone/remdesevir. The patient did require supplemental oxygen (1-2L) for a few days but this was stopped several days prior to discharge. Discharged to home.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Lung opacity, Procalcitonin, Pyrexia, Respiratory tract congestion
Clinical narrative: Narrative: 66 y/o male with Hx of obesity, DM2, HLD and 2 out of 2 COVID vaccination who presents with fever, cough, fatigue. The patient states that he recently has been exposed to his granddaughter who tested positive on Aug 16th. Since that time the patient states he developed symptoms such as fever, dry cough, congestion, diarrhea, headache. In the next few days he himself tested positive outside the Facility on Aug 18th. He tried to quarantine at home but symptoms worsened and therefore presented to the ED. COVID positive. HR 85, BP 105/80, RR 18, On 3L nasal cannula. Labs showed, BUN 26, Cr 1.22, AST 97, ALT 71, CBC/INR normal, Trop neg, BNP normal. CPK 448, CRP 147, Procal 1.41, Ferritin >2000, LDH 538. Ddimer 1.21. CTA: negative for PE, moderate GGO's in bilateral lungs consistent for COVID pneumonia. He was admitted to the medicine service. HOSPITAL COURSE: The patient was admitted to the hospitalist service. Covid pneumonia with hypoxemia - Patient treated with course of dexamethasone/remdesevir. The patient did require supplemental oxygen (1-2L) for a few days but this was stopped several days prior to discharge. Discharged to home.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Serum ferritin increased, Troponin normal
Clinical narrative: Narrative: 66 y/o male with Hx of obesity, DM2, HLD and 2 out of 2 COVID vaccination who presents with fever, cough, fatigue. The patient states that he recently has been exposed to his granddaughter who tested positive on Aug 16th. Since that time the patient states he developed symptoms such as fever, dry cough, congestion, diarrhea, headache. In the next few days he himself tested positive outside the Facility on Aug 18th. He tried to quarantine at home but symptoms worsened and therefore presented to the ED. COVID positive. HR 85, BP 105/80, RR 18, On 3L nasal cannula. Labs showed, BUN 26, Cr 1.22, AST 97, ALT 71, CBC/INR normal, Trop neg, BNP normal. CPK 448, CRP 147, Procal 1.41, Ferritin >2000, LDH 538. Ddimer 1.21. CTA: negative for PE, moderate GGO's in bilateral lungs consistent for COVID pneumonia. He was admitted to the medicine service. HOSPITAL COURSE: The patient was admitted to the hospitalist service. Covid pneumonia with hypoxemia - Patient treated with course of dexamethasone/remdesevir. The patient did require supplemental oxygen (1-2L) for a few days but this was stopped several days prior to discharge. Discharged to home.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Atrial fibrillation, COVID-19, Decreased appetite, Discomfort
Clinical narrative: Narrative: 79 year old MALE who presented for outpatient cardiac stress test, was noted with rapid heart rate of 140+. Transitioned to the ED, noted with atrial fibrillation and RVE, and febrile. Further testing shows Covid 19 positivity. Patient states he thought he wasn't suppose to eat or drink for 2 days prior to testing. Also hasn't taken his medications  for 2 days. ED tx includes diltiazem 10 mg\IV, metoprolol 5 mg IV times 3 with reasonable response. Patient became quite tachycardic in ED with movement and slightly winded. Placed on 3 LPM oxygen support in ED, also with acute on chronic renal failure. Patient was admitted to MICU overflow and downgraded next day. HOSPITAL COURSE: slow improvement in appetite, and overall comfort. Discharged home, to quarantine additional 8 days for COVID infection.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Fluid intake reduced, Heart rate increased, Hypophagia, Intensive care
Clinical narrative: Narrative: 79 year old MALE who presented for outpatient cardiac stress test, was noted with rapid heart rate of 140+. Transitioned to the ED, noted with atrial fibrillation and RVE, and febrile. Further testing shows Covid 19 positivity. Patient states he thought he wasn't suppose to eat or drink for 2 days prior to testing. Also hasn't taken his medications  for 2 days. ED tx includes diltiazem 10 mg\IV, metoprolol 5 mg IV times 3 with reasonable response. Patient became quite tachycardic in ED with movement and slightly winded. Placed on 3 LPM oxygen support in ED, also with acute on chronic renal failure. Patient was admitted to MICU overflow and downgraded next day. HOSPITAL COURSE: slow improvement in appetite, and overall comfort. Discharged home, to quarantine additional 8 days for COVID infection.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Right ventricular enlargement, SARS-CoV-2 test positive, Tachycardia, Therapy cessation
Clinical narrative: Narrative: 79 year old MALE who presented for outpatient cardiac stress test, was noted with rapid heart rate of 140+. Transitioned to the ED, noted with atrial fibrillation and RVE, and febrile. Further testing shows Covid 19 positivity. Patient states he thought he wasn't suppose to eat or drink for 2 days prior to testing. Also hasn't taken his medications  for 2 days. ED tx includes diltiazem 10 mg\IV, metoprolol 5 mg IV times 3 with reasonable response. Patient became quite tachycardic in ED with movement and slightly winded. Placed on 3 LPM oxygen support in ED, also with acute on chronic renal failure. Patient was admitted to MICU overflow and downgraded next day. HOSPITAL COURSE: slow improvement in appetite, and overall comfort. Discharged home, to quarantine additional 8 days for COVID infection.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Malignant melanoma, Metastases to liver, Metastases to lymph nodes
Clinical narrative: Narrative:  59yo male patient died at home from cancer (melanoma primary with metastases to liver and lymph nodes. Pt died on 9/15/2021. Pt had received covid vaccines on 1/21/21 & on 2/23/21. Likely vaccines not related to pt's death given pt's terminal medical diagnosis & long length of time between vaccines and date of death.
Age: 103.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Death, Decreased appetite
Clinical narrative: Narrative:  103yo male died at his assisted living facility after having a stroke. Pt's son reported that his father was at an ALF and had a stroke a week ago and wasn't eating. "He just dies of old age. He was 103 years old." Pt had received covid vaccines from same facility on 2/20/2021 & 4/19/2021. This death likely is not related to covid vaccines given pt's advanced age & stroke listed as cause of death. ALso great time between date of vaccines and date of death.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cardiomegaly, Chest X-ray abnormal
Clinical narrative: Narrative: 71 yo male presented to the Emergency Dept on 9/7/2021 with complaints of of fatigue and fever x1 week. Patient has history of mild-moderate aortic stenosis w/ mild aortic insufficiency, non-obstructive CAD (LHC '19), HFpEF, PVCs/NSVT, HTN, HLD, OSA, CKD, hypothyroidism and peripheral neuropathy. Tested COVID+ on 9/7/2021 despite being fully vaccinated with Moderna Covid vaccination on 1/20/2021 and 2/19/2021. He received monoclonal antibody on 9/7. He felt better, but then developed worsening fevers, cough, and dyspnea. He presented to the ED on 9/11 for further evaluation. He had oxygen desaturation to the 80s and was placed on supplemental oxygen by nasal cannula. CXR demonstrated evidence of COVID pneumonia. He was given dexamethasone, ceftriaxone, and azithromycin and admitted for further management. He had acute hypoxic respiratory failure and no clear evidence for bacterial superinfection. He was discharged after 2 days at his request, in stable condition.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea, Fatigue, Lung opacity, Oxygen saturation decreased
Clinical narrative: Narrative: 71 yo male presented to the Emergency Dept on 9/7/2021 with complaints of of fatigue and fever x1 week. Patient has history of mild-moderate aortic stenosis w/ mild aortic insufficiency, non-obstructive CAD (LHC '19), HFpEF, PVCs/NSVT, HTN, HLD, OSA, CKD, hypothyroidism and peripheral neuropathy. Tested COVID+ on 9/7/2021 despite being fully vaccinated with Moderna Covid vaccination on 1/20/2021 and 2/19/2021. He received monoclonal antibody on 9/7. He felt better, but then developed worsening fevers, cough, and dyspnea. He presented to the ED on 9/11 for further evaluation. He had oxygen desaturation to the 80s and was placed on supplemental oxygen by nasal cannula. CXR demonstrated evidence of COVID pneumonia. He was given dexamethasone, ceftriaxone, and azithromycin and admitted for further management. He had acute hypoxic respiratory failure and no clear evidence for bacterial superinfection. He was discharged after 2 days at his request, in stable condition.
Age: 72.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Superinfection bacterial
Clinical narrative: Narrative: 71 yo male presented to the Emergency Dept on 9/7/2021 with complaints of of fatigue and fever x1 week. Patient has history of mild-moderate aortic stenosis w/ mild aortic insufficiency, non-obstructive CAD (LHC '19), HFpEF, PVCs/NSVT, HTN, HLD, OSA, CKD, hypothyroidism and peripheral neuropathy. Tested COVID+ on 9/7/2021 despite being fully vaccinated with Moderna Covid vaccination on 1/20/2021 and 2/19/2021. He received monoclonal antibody on 9/7. He felt better, but then developed worsening fevers, cough, and dyspnea. He presented to the ED on 9/11 for further evaluation. He had oxygen desaturation to the 80s and was placed on supplemental oxygen by nasal cannula. CXR demonstrated evidence of COVID pneumonia. He was given dexamethasone, ceftriaxone, and azithromycin and admitted for further management. He had acute hypoxic respiratory failure and no clear evidence for bacterial superinfection. He was discharged after 2 days at his request, in stable condition.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Bone cancer, Death, Lymphoma, Malignant neoplasm of spinal cord, Soft tissue sarcoma
Clinical narrative: Narrative:  62yo male patient with cancer of soft tissue, lymph nodes in face, liver, & bone with new spinal cord involvement per 9/13/2021 MD note died on 9/27/21 at HOSPITAL. Pt had received covid vaccines on 1/28/21 & 4/6/2021. Likely this death is not related to covid vaccines given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Activated partial thromboplastin time shortened, Anti factor Xa assay, Blood fibrinogen increased, COVID-19
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19/2021, Pfizer, dose #1 04/12/2021, Pfizer, dose #2 03/06/2021 outside hospitalization dx: nephrolithiasis, UTI, calculus of kidney & ureter, hydronephrosis with obstruction callus LOS: 3 days 03/13/2021 outside hospitalization dx renal colic LOS: 1 day 03/29/2021 outside hospitalization dx bilat ureteroscopy, laser lithotripsy& indwelling double j ureteral stent exchange 07/07/2021 outside hospitalization dx complicated UTI LOS: 1 day 08/03/2021 ED admission: pt cc: flank pain, SOB, chronic cough, chest pain, abdominal pain, nausea, exposure: unknown 08/4/2021 COVID swab, result: detected 08/4/2021DVT while in the hospital for Covid19 08/4/2021 Troponin I result: <0.016 08/4/2021 COVID swab result: detected 08/4/2021 DDIMER result: 3.71 08/4/2021 PT/ APTT/ INR 14.7/ 26.4/ 1.31 08/4/2021 Amto-Xa Unfractionated Heparin <0.04 08/4/2021 Fibrinogen result: 491 08/4/2021 ct abd/pelvis impression: Multiple nonobstructing intrarenal stones. No obstructing or ureteral stones. Groundglass in the lung bases in keeping with hazy opacities demonstrated on recent chest radiograph, likely infectious. 08/4/2021 CXR impression: Multifocal pneumonia. The appearance can be seen with viral pneumonia as an atypical pneumonia is the correct clinical setting. 08/5/2021 ESR result: 53 08/5/2021 fibrinogen/ DDMER result: 459/ 0.69 08/6/2021 ESR result: 39 08/6/2021 fibrinogen/ DDMER result: 378 /1.18 08/7/2021 ESR result: 35 08/7/2021 fibrinogen/ DDMER result: 365/ 3.30 08/8/2021 ESR result: 20 08/8/2021 fibrinogen/ DDMER result: 300/ 5.07 08/9/2021 ESR result: 11 08/9/2021 fibrinogen/ DDMER result: 261/ 7.28 08/10/2021 ESR result: 13 08/10/2021 fibrinogen/ DDMER result: 261/ 6.21 08/10/2021 PT/ INR result: 12.2/ 1.09 08/10/2021 US Doppler bilat lower ext result: Nonocclusive but mobile thrombus within the proximal right popliteal vein 08/11/2021 PT/ INR result: 14.2/ 1.27 08/16/2021 PT/ INR result: 80.2/ 7.16 08/24/2021 PT/ INR result: 24.8/ 2.21 09/2/2021 PT/INR result: 24.9 /2.22
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chest pain, Computerised tomogram abdomen abnormal, Condition aggravated, Cough
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19/2021, Pfizer, dose #1 04/12/2021, Pfizer, dose #2 03/06/2021 outside hospitalization dx: nephrolithiasis, UTI, calculus of kidney & ureter, hydronephrosis with obstruction callus LOS: 3 days 03/13/2021 outside hospitalization dx renal colic LOS: 1 day 03/29/2021 outside hospitalization dx bilat ureteroscopy, laser lithotripsy& indwelling double j ureteral stent exchange 07/07/2021 outside hospitalization dx complicated UTI LOS: 1 day 08/03/2021 ED admission: pt cc: flank pain, SOB, chronic cough, chest pain, abdominal pain, nausea, exposure: unknown 08/4/2021 COVID swab, result: detected 08/4/2021DVT while in the hospital for Covid19 08/4/2021 Troponin I result: <0.016 08/4/2021 COVID swab result: detected 08/4/2021 DDIMER result: 3.71 08/4/2021 PT/ APTT/ INR 14.7/ 26.4/ 1.31 08/4/2021 Amto-Xa Unfractionated Heparin <0.04 08/4/2021 Fibrinogen result: 491 08/4/2021 ct abd/pelvis impression: Multiple nonobstructing intrarenal stones. No obstructing or ureteral stones. Groundglass in the lung bases in keeping with hazy opacities demonstrated on recent chest radiograph, likely infectious. 08/4/2021 CXR impression: Multifocal pneumonia. The appearance can be seen with viral pneumonia as an atypical pneumonia is the correct clinical setting. 08/5/2021 ESR result: 53 08/5/2021 fibrinogen/ DDMER result: 459/ 0.69 08/6/2021 ESR result: 39 08/6/2021 fibrinogen/ DDMER result: 378 /1.18 08/7/2021 ESR result: 35 08/7/2021 fibrinogen/ DDMER result: 365/ 3.30 08/8/2021 ESR result: 20 08/8/2021 fibrinogen/ DDMER result: 300/ 5.07 08/9/2021 ESR result: 11 08/9/2021 fibrinogen/ DDMER result: 261/ 7.28 08/10/2021 ESR result: 13 08/10/2021 fibrinogen/ DDMER result: 261/ 6.21 08/10/2021 PT/ INR result: 12.2/ 1.09 08/10/2021 US Doppler bilat lower ext result: Nonocclusive but mobile thrombus within the proximal right popliteal vein 08/11/2021 PT/ INR result: 14.2/ 1.27 08/16/2021 PT/ INR result: 80.2/ 7.16 08/24/2021 PT/ INR result: 24.8/ 2.21 09/2/2021 PT/INR result: 24.9 /2.22
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Dyspnoea, Fibrin D dimer, Flank pain, International normalised ratio increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19/2021, Pfizer, dose #1 04/12/2021, Pfizer, dose #2 03/06/2021 outside hospitalization dx: nephrolithiasis, UTI, calculus of kidney & ureter, hydronephrosis with obstruction callus LOS: 3 days 03/13/2021 outside hospitalization dx renal colic LOS: 1 day 03/29/2021 outside hospitalization dx bilat ureteroscopy, laser lithotripsy& indwelling double j ureteral stent exchange 07/07/2021 outside hospitalization dx complicated UTI LOS: 1 day 08/03/2021 ED admission: pt cc: flank pain, SOB, chronic cough, chest pain, abdominal pain, nausea, exposure: unknown 08/4/2021 COVID swab, result: detected 08/4/2021DVT while in the hospital for Covid19 08/4/2021 Troponin I result: <0.016 08/4/2021 COVID swab result: detected 08/4/2021 DDIMER result: 3.71 08/4/2021 PT/ APTT/ INR 14.7/ 26.4/ 1.31 08/4/2021 Amto-Xa Unfractionated Heparin <0.04 08/4/2021 Fibrinogen result: 491 08/4/2021 ct abd/pelvis impression: Multiple nonobstructing intrarenal stones. No obstructing or ureteral stones. Groundglass in the lung bases in keeping with hazy opacities demonstrated on recent chest radiograph, likely infectious. 08/4/2021 CXR impression: Multifocal pneumonia. The appearance can be seen with viral pneumonia as an atypical pneumonia is the correct clinical setting. 08/5/2021 ESR result: 53 08/5/2021 fibrinogen/ DDMER result: 459/ 0.69 08/6/2021 ESR result: 39 08/6/2021 fibrinogen/ DDMER result: 378 /1.18 08/7/2021 ESR result: 35 08/7/2021 fibrinogen/ DDMER result: 365/ 3.30 08/8/2021 ESR result: 20 08/8/2021 fibrinogen/ DDMER result: 300/ 5.07 08/9/2021 ESR result: 11 08/9/2021 fibrinogen/ DDMER result: 261/ 7.28 08/10/2021 ESR result: 13 08/10/2021 fibrinogen/ DDMER result: 261/ 6.21 08/10/2021 PT/ INR result: 12.2/ 1.09 08/10/2021 US Doppler bilat lower ext result: Nonocclusive but mobile thrombus within the proximal right popliteal vein 08/11/2021 PT/ INR result: 14.2/ 1.27 08/16/2021 PT/ INR result: 80.2/ 7.16 08/24/2021 PT/ INR result: 24.8/ 2.21 09/2/2021 PT/INR result: 24.9 /2.22
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Lung opacity, Nausea, Nephrolithiasis, Pneumonia, Prothrombin time prolonged
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19/2021, Pfizer, dose #1 04/12/2021, Pfizer, dose #2 03/06/2021 outside hospitalization dx: nephrolithiasis, UTI, calculus of kidney & ureter, hydronephrosis with obstruction callus LOS: 3 days 03/13/2021 outside hospitalization dx renal colic LOS: 1 day 03/29/2021 outside hospitalization dx bilat ureteroscopy, laser lithotripsy& indwelling double j ureteral stent exchange 07/07/2021 outside hospitalization dx complicated UTI LOS: 1 day 08/03/2021 ED admission: pt cc: flank pain, SOB, chronic cough, chest pain, abdominal pain, nausea, exposure: unknown 08/4/2021 COVID swab, result: detected 08/4/2021DVT while in the hospital for Covid19 08/4/2021 Troponin I result: <0.016 08/4/2021 COVID swab result: detected 08/4/2021 DDIMER result: 3.71 08/4/2021 PT/ APTT/ INR 14.7/ 26.4/ 1.31 08/4/2021 Amto-Xa Unfractionated Heparin <0.04 08/4/2021 Fibrinogen result: 491 08/4/2021 ct abd/pelvis impression: Multiple nonobstructing intrarenal stones. No obstructing or ureteral stones. Groundglass in the lung bases in keeping with hazy opacities demonstrated on recent chest radiograph, likely infectious. 08/4/2021 CXR impression: Multifocal pneumonia. The appearance can be seen with viral pneumonia as an atypical pneumonia is the correct clinical setting. 08/5/2021 ESR result: 53 08/5/2021 fibrinogen/ DDMER result: 459/ 0.69 08/6/2021 ESR result: 39 08/6/2021 fibrinogen/ DDMER result: 378 /1.18 08/7/2021 ESR result: 35 08/7/2021 fibrinogen/ DDMER result: 365/ 3.30 08/8/2021 ESR result: 20 08/8/2021 fibrinogen/ DDMER result: 300/ 5.07 08/9/2021 ESR result: 11 08/9/2021 fibrinogen/ DDMER result: 261/ 7.28 08/10/2021 ESR result: 13 08/10/2021 fibrinogen/ DDMER result: 261/ 6.21 08/10/2021 PT/ INR result: 12.2/ 1.09 08/10/2021 US Doppler bilat lower ext result: Nonocclusive but mobile thrombus within the proximal right popliteal vein 08/11/2021 PT/ INR result: 14.2/ 1.27 08/16/2021 PT/ INR result: 80.2/ 7.16 08/24/2021 PT/ INR result: 24.8/ 2.21 09/2/2021 PT/INR result: 24.9 /2.22
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Renal atrophy, SARS-CoV-2 test positive, Troponin I normal, Ultrasound Doppler abnormal
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19/2021, Pfizer, dose #1 04/12/2021, Pfizer, dose #2 03/06/2021 outside hospitalization dx: nephrolithiasis, UTI, calculus of kidney & ureter, hydronephrosis with obstruction callus LOS: 3 days 03/13/2021 outside hospitalization dx renal colic LOS: 1 day 03/29/2021 outside hospitalization dx bilat ureteroscopy, laser lithotripsy& indwelling double j ureteral stent exchange 07/07/2021 outside hospitalization dx complicated UTI LOS: 1 day 08/03/2021 ED admission: pt cc: flank pain, SOB, chronic cough, chest pain, abdominal pain, nausea, exposure: unknown 08/4/2021 COVID swab, result: detected 08/4/2021DVT while in the hospital for Covid19 08/4/2021 Troponin I result: <0.016 08/4/2021 COVID swab result: detected 08/4/2021 DDIMER result: 3.71 08/4/2021 PT/ APTT/ INR 14.7/ 26.4/ 1.31 08/4/2021 Amto-Xa Unfractionated Heparin <0.04 08/4/2021 Fibrinogen result: 491 08/4/2021 ct abd/pelvis impression: Multiple nonobstructing intrarenal stones. No obstructing or ureteral stones. Groundglass in the lung bases in keeping with hazy opacities demonstrated on recent chest radiograph, likely infectious. 08/4/2021 CXR impression: Multifocal pneumonia. The appearance can be seen with viral pneumonia as an atypical pneumonia is the correct clinical setting. 08/5/2021 ESR result: 53 08/5/2021 fibrinogen/ DDMER result: 459/ 0.69 08/6/2021 ESR result: 39 08/6/2021 fibrinogen/ DDMER result: 378 /1.18 08/7/2021 ESR result: 35 08/7/2021 fibrinogen/ DDMER result: 365/ 3.30 08/8/2021 ESR result: 20 08/8/2021 fibrinogen/ DDMER result: 300/ 5.07 08/9/2021 ESR result: 11 08/9/2021 fibrinogen/ DDMER result: 261/ 7.28 08/10/2021 ESR result: 13 08/10/2021 fibrinogen/ DDMER result: 261/ 6.21 08/10/2021 PT/ INR result: 12.2/ 1.09 08/10/2021 US Doppler bilat lower ext result: Nonocclusive but mobile thrombus within the proximal right popliteal vein 08/11/2021 PT/ INR result: 14.2/ 1.27 08/16/2021 PT/ INR result: 80.2/ 7.16 08/24/2021 PT/ INR result: 24.8/ 2.21 09/2/2021 PT/INR result: 24.9 /2.22
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Ureteral stent removal, Urinary tract infection
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19/2021, Pfizer, dose #1 04/12/2021, Pfizer, dose #2 03/06/2021 outside hospitalization dx: nephrolithiasis, UTI, calculus of kidney & ureter, hydronephrosis with obstruction callus LOS: 3 days 03/13/2021 outside hospitalization dx renal colic LOS: 1 day 03/29/2021 outside hospitalization dx bilat ureteroscopy, laser lithotripsy& indwelling double j ureteral stent exchange 07/07/2021 outside hospitalization dx complicated UTI LOS: 1 day 08/03/2021 ED admission: pt cc: flank pain, SOB, chronic cough, chest pain, abdominal pain, nausea, exposure: unknown 08/4/2021 COVID swab, result: detected 08/4/2021DVT while in the hospital for Covid19 08/4/2021 Troponin I result: <0.016 08/4/2021 COVID swab result: detected 08/4/2021 DDIMER result: 3.71 08/4/2021 PT/ APTT/ INR 14.7/ 26.4/ 1.31 08/4/2021 Amto-Xa Unfractionated Heparin <0.04 08/4/2021 Fibrinogen result: 491 08/4/2021 ct abd/pelvis impression: Multiple nonobstructing intrarenal stones. No obstructing or ureteral stones. Groundglass in the lung bases in keeping with hazy opacities demonstrated on recent chest radiograph, likely infectious. 08/4/2021 CXR impression: Multifocal pneumonia. The appearance can be seen with viral pneumonia as an atypical pneumonia is the correct clinical setting. 08/5/2021 ESR result: 53 08/5/2021 fibrinogen/ DDMER result: 459/ 0.69 08/6/2021 ESR result: 39 08/6/2021 fibrinogen/ DDMER result: 378 /1.18 08/7/2021 ESR result: 35 08/7/2021 fibrinogen/ DDMER result: 365/ 3.30 08/8/2021 ESR result: 20 08/8/2021 fibrinogen/ DDMER result: 300/ 5.07 08/9/2021 ESR result: 11 08/9/2021 fibrinogen/ DDMER result: 261/ 7.28 08/10/2021 ESR result: 13 08/10/2021 fibrinogen/ DDMER result: 261/ 6.21 08/10/2021 PT/ INR result: 12.2/ 1.09 08/10/2021 US Doppler bilat lower ext result: Nonocclusive but mobile thrombus within the proximal right popliteal vein 08/11/2021 PT/ INR result: 14.2/ 1.27 08/16/2021 PT/ INR result: 80.2/ 7.16 08/24/2021 PT/ INR result: 24.8/ 2.21 09/2/2021 PT/INR result: 24.9 /2.22
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, COVID-19, Haemoptysis, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID-19 hospitalization in fully vaccinated person. Tested positive 8/19/21. Admitted 8/26/21 with acute hypoxic respiratory failure secondary to COVID-19. On arrival, satting 75% on room air. Improved with supplemental oxygen via NC, intermittently requiring HFNC. Received dexamethasone and remdesivir during hospitalization. Received short term (4 day) antibiotic coverage for CAP but discontinued given no signs/symptoms of superimposed bacterial pneumonia. Some hemoptysis during hospitalization, CTA chest negative for PE. Oxygen needs slowly decreased, weaned to room air on 9/5. Required some oxygen with activity. Discharged 9/6 in stable condition with supplemental oxygen with activity.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Blood bicarbonate increased, Blood creatine phosphokinase increased, Blood fibrinogen increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 08/12 pt cc: has dementia exposure: unknown 08/12 pt admit to Medicine dx :Acute Hypoxic Respiratory Failure due to COVID-19 Infection LOC: 18 08/13 - 08/26 pt symptoms continue 08/12 TROPONIN I result: 0.036 08/12 COVID swab, result: detected 08/12 BNP result: 506.6 08/12 CK CREATINE KINASE result: 382.0 08/12 TROPONIN I result: 0.078 08/12 CXR impression: No acute cardiopulmonary abnormality or change since 6/3/2021. 08/13 DDIMER result: 2.11 08/13 CTA PE impression: . No pulmonary embolus to the subsegmental level. 2. Thick-walled central bronchi could reflect ongoing bronchitis. This may account for the patient's hypoxemia and might be secondary to ongoing COVID. Centrilobular groundglass opacities in the RUL and LLL may reflect ongoing/developing COVID pneumonitis. 08/14 ESR result: 21 08/15 CXR impression: No acute cardiopulmonary disease 08/19 ABG i-pH 7.47, i-PCO2 38.5, i-PO2 74, i-HCO3 28.2 08/19 CXR impression: Possibly worsening bronchiolitis in the LEFT lower lobe. No convincing bronchopneumonia. Remainder of findings as above 08/20 CXR impression: No acute cardiopulmonary disease. 08/21 ESR result: 23 08/21 FIBRINOGEN result: 384 08/21 DDIMER result: 3.52 08/22 ESR result: 2 08/22 FIBRINOGEN result: 359 08/22 DDIMER result: 3.09 08/23 ESR result: 4 08/23 FIBRINOGEN result: 321 08/23 DDIMER result: 3.46 08/24 ESR result: 15 08/24 SAR-COV-2 IgG result: 2.44 08/24 BNP result: 169.7 08/24 SARS-COV-2 TOTAL AB SPIKE result: >2500.0 08/27 clinically resolved
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Blood gases, Blood pH increased, Brain natriuretic peptide increased, Bronchial wall thickening, COVID-19
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 08/12 pt cc: has dementia exposure: unknown 08/12 pt admit to Medicine dx :Acute Hypoxic Respiratory Failure due to COVID-19 Infection LOC: 18 08/13 - 08/26 pt symptoms continue 08/12 TROPONIN I result: 0.036 08/12 COVID swab, result: detected 08/12 BNP result: 506.6 08/12 CK CREATINE KINASE result: 382.0 08/12 TROPONIN I result: 0.078 08/12 CXR impression: No acute cardiopulmonary abnormality or change since 6/3/2021. 08/13 DDIMER result: 2.11 08/13 CTA PE impression: . No pulmonary embolus to the subsegmental level. 2. Thick-walled central bronchi could reflect ongoing bronchitis. This may account for the patient's hypoxemia and might be secondary to ongoing COVID. Centrilobular groundglass opacities in the RUL and LLL may reflect ongoing/developing COVID pneumonitis. 08/14 ESR result: 21 08/15 CXR impression: No acute cardiopulmonary disease 08/19 ABG i-pH 7.47, i-PCO2 38.5, i-PO2 74, i-HCO3 28.2 08/19 CXR impression: Possibly worsening bronchiolitis in the LEFT lower lobe. No convincing bronchopneumonia. Remainder of findings as above 08/20 CXR impression: No acute cardiopulmonary disease. 08/21 ESR result: 23 08/21 FIBRINOGEN result: 384 08/21 DDIMER result: 3.52 08/22 ESR result: 2 08/22 FIBRINOGEN result: 359 08/22 DDIMER result: 3.09 08/23 ESR result: 4 08/23 FIBRINOGEN result: 321 08/23 DDIMER result: 3.46 08/24 ESR result: 15 08/24 SAR-COV-2 IgG result: 2.44 08/24 BNP result: 169.7 08/24 SARS-COV-2 TOTAL AB SPIKE result: >2500.0 08/27 clinically resolved
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray normal, Dementia, Fibrin D dimer, Hypoxia, Lung opacity
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 08/12 pt cc: has dementia exposure: unknown 08/12 pt admit to Medicine dx :Acute Hypoxic Respiratory Failure due to COVID-19 Infection LOC: 18 08/13 - 08/26 pt symptoms continue 08/12 TROPONIN I result: 0.036 08/12 COVID swab, result: detected 08/12 BNP result: 506.6 08/12 CK CREATINE KINASE result: 382.0 08/12 TROPONIN I result: 0.078 08/12 CXR impression: No acute cardiopulmonary abnormality or change since 6/3/2021. 08/13 DDIMER result: 2.11 08/13 CTA PE impression: . No pulmonary embolus to the subsegmental level. 2. Thick-walled central bronchi could reflect ongoing bronchitis. This may account for the patient's hypoxemia and might be secondary to ongoing COVID. Centrilobular groundglass opacities in the RUL and LLL may reflect ongoing/developing COVID pneumonitis. 08/14 ESR result: 21 08/15 CXR impression: No acute cardiopulmonary disease 08/19 ABG i-pH 7.47, i-PCO2 38.5, i-PO2 74, i-HCO3 28.2 08/19 CXR impression: Possibly worsening bronchiolitis in the LEFT lower lobe. No convincing bronchopneumonia. Remainder of findings as above 08/20 CXR impression: No acute cardiopulmonary disease. 08/21 ESR result: 23 08/21 FIBRINOGEN result: 384 08/21 DDIMER result: 3.52 08/22 ESR result: 2 08/22 FIBRINOGEN result: 359 08/22 DDIMER result: 3.09 08/23 ESR result: 4 08/23 FIBRINOGEN result: 321 08/23 DDIMER result: 3.46 08/24 ESR result: 15 08/24 SAR-COV-2 IgG result: 2.44 08/24 BNP result: 169.7 08/24 SARS-COV-2 TOTAL AB SPIKE result: >2500.0 08/27 clinically resolved
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: PCO2 normal, PO2 decreased, Red blood cell sedimentation rate increased, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 08/12 pt cc: has dementia exposure: unknown 08/12 pt admit to Medicine dx :Acute Hypoxic Respiratory Failure due to COVID-19 Infection LOC: 18 08/13 - 08/26 pt symptoms continue 08/12 TROPONIN I result: 0.036 08/12 COVID swab, result: detected 08/12 BNP result: 506.6 08/12 CK CREATINE KINASE result: 382.0 08/12 TROPONIN I result: 0.078 08/12 CXR impression: No acute cardiopulmonary abnormality or change since 6/3/2021. 08/13 DDIMER result: 2.11 08/13 CTA PE impression: . No pulmonary embolus to the subsegmental level. 2. Thick-walled central bronchi could reflect ongoing bronchitis. This may account for the patient's hypoxemia and might be secondary to ongoing COVID. Centrilobular groundglass opacities in the RUL and LLL may reflect ongoing/developing COVID pneumonitis. 08/14 ESR result: 21 08/15 CXR impression: No acute cardiopulmonary disease 08/19 ABG i-pH 7.47, i-PCO2 38.5, i-PO2 74, i-HCO3 28.2 08/19 CXR impression: Possibly worsening bronchiolitis in the LEFT lower lobe. No convincing bronchopneumonia. Remainder of findings as above 08/20 CXR impression: No acute cardiopulmonary disease. 08/21 ESR result: 23 08/21 FIBRINOGEN result: 384 08/21 DDIMER result: 3.52 08/22 ESR result: 2 08/22 FIBRINOGEN result: 359 08/22 DDIMER result: 3.09 08/23 ESR result: 4 08/23 FIBRINOGEN result: 321 08/23 DDIMER result: 3.46 08/24 ESR result: 15 08/24 SAR-COV-2 IgG result: 2.44 08/24 BNP result: 169.7 08/24 SARS-COV-2 TOTAL AB SPIKE result: >2500.0 08/27 clinically resolved
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/18, Pfizer, dose #1 04/08, Pfizer, dose #2 08/12 pt cc: has dementia exposure: unknown 08/12 pt admit to Medicine dx :Acute Hypoxic Respiratory Failure due to COVID-19 Infection LOC: 18 08/13 - 08/26 pt symptoms continue 08/12 TROPONIN I result: 0.036 08/12 COVID swab, result: detected 08/12 BNP result: 506.6 08/12 CK CREATINE KINASE result: 382.0 08/12 TROPONIN I result: 0.078 08/12 CXR impression: No acute cardiopulmonary abnormality or change since 6/3/2021. 08/13 DDIMER result: 2.11 08/13 CTA PE impression: . No pulmonary embolus to the subsegmental level. 2. Thick-walled central bronchi could reflect ongoing bronchitis. This may account for the patient's hypoxemia and might be secondary to ongoing COVID. Centrilobular groundglass opacities in the RUL and LLL may reflect ongoing/developing COVID pneumonitis. 08/14 ESR result: 21 08/15 CXR impression: No acute cardiopulmonary disease 08/19 ABG i-pH 7.47, i-PCO2 38.5, i-PO2 74, i-HCO3 28.2 08/19 CXR impression: Possibly worsening bronchiolitis in the LEFT lower lobe. No convincing bronchopneumonia. Remainder of findings as above 08/20 CXR impression: No acute cardiopulmonary disease. 08/21 ESR result: 23 08/21 FIBRINOGEN result: 384 08/21 DDIMER result: 3.52 08/22 ESR result: 2 08/22 FIBRINOGEN result: 359 08/22 DDIMER result: 3.09 08/23 ESR result: 4 08/23 FIBRINOGEN result: 321 08/23 DDIMER result: 3.46 08/24 ESR result: 15 08/24 SAR-COV-2 IgG result: 2.44 08/24 BNP result: 169.7 08/24 SARS-COV-2 TOTAL AB SPIKE result: >2500.0 08/27 clinically resolved
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time normal, Anti factor Xa assay, Asthenia, Blood bicarbonate decreased, Blood fibrinogen decreased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/29, Pfizer, dose #1 (Non-agency) 02/20, Pfizer, dose #2 (Non-agency) 08/03 pt cc: cough, fatigue, headache, dyspnea, severe weakness, chills, diarrhea, exposure: possible wife or daughter 08/06 COVID swab, result: detected 08/06 ED admit dx: covid pna admit to medicine LOS: 2 days 08/12 Another ED admission with direction admission to medicine dx: COVID19 with progressively worsening 08/24 CXR impression: Similar left tension pneumothorax. Redemonstrated left-sided chest tube has its tip projecting over central left lung zone. 08/25 fungitel interpretation negative result: 31 08/26 PT result 14.6, APTT result: 39.3, INR result 1.30, antiXa unfrac 0.32 08/26 lactic acid result: 2.02 08/26 procalcitonin result: 0.55 08/26 troponin i result: 2.469 08/26 MRSA result: not detected 08/27 SARS-CoV-IgG result: 2.23 08/29 CXR impression: Limited study. Increased moderate pneumomediastinum. ET tube tip about 4.4 cm above the carina. No obvious pneumothorax seen. Extensive airspace disease on the left appears mildly increased. Mild right perihilar infiltrate appears similar 08/30 CXR impression: Slight further increase in pneumomediastinum. 2. More prominent burden of airspace opacities, as above. 3. Tubes and lines as above. 08/31 ABG (ventilator) i-Ph 7.17, I-pco2 47.5, i-Po2 72, iHCO3 17.2, 08/31 FIBRINOGEN result: 161 08/31 DDIMER result: 14.59 08/31 ESR 4 08/31 lactic acid 8.13 08/31 ANTI-XA UFH result: 0.26 08/31 decease
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, Blood pH decreased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/29, Pfizer, dose #1 (Non-agency) 02/20, Pfizer, dose #2 (Non-agency) 08/03 pt cc: cough, fatigue, headache, dyspnea, severe weakness, chills, diarrhea, exposure: possible wife or daughter 08/06 COVID swab, result: detected 08/06 ED admit dx: covid pna admit to medicine LOS: 2 days 08/12 Another ED admission with direction admission to medicine dx: COVID19 with progressively worsening 08/24 CXR impression: Similar left tension pneumothorax. Redemonstrated left-sided chest tube has its tip projecting over central left lung zone. 08/25 fungitel interpretation negative result: 31 08/26 PT result 14.6, APTT result: 39.3, INR result 1.30, antiXa unfrac 0.32 08/26 lactic acid result: 2.02 08/26 procalcitonin result: 0.55 08/26 troponin i result: 2.469 08/26 MRSA result: not detected 08/27 SARS-CoV-IgG result: 2.23 08/29 CXR impression: Limited study. Increased moderate pneumomediastinum. ET tube tip about 4.4 cm above the carina. No obvious pneumothorax seen. Extensive airspace disease on the left appears mildly increased. Mild right perihilar infiltrate appears similar 08/30 CXR impression: Slight further increase in pneumomediastinum. 2. More prominent burden of airspace opacities, as above. 3. Tubes and lines as above. 08/31 ABG (ventilator) i-Ph 7.17, I-pco2 47.5, i-Po2 72, iHCO3 17.2, 08/31 FIBRINOGEN result: 161 08/31 DDIMER result: 14.59 08/31 ESR 4 08/31 lactic acid 8.13 08/31 ANTI-XA UFH result: 0.26 08/31 decease
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Chest tube insertion, Chills, Cough, Diarrhoea, Dyspnoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/29, Pfizer, dose #1 (Non-agency) 02/20, Pfizer, dose #2 (Non-agency) 08/03 pt cc: cough, fatigue, headache, dyspnea, severe weakness, chills, diarrhea, exposure: possible wife or daughter 08/06 COVID swab, result: detected 08/06 ED admit dx: covid pna admit to medicine LOS: 2 days 08/12 Another ED admission with direction admission to medicine dx: COVID19 with progressively worsening 08/24 CXR impression: Similar left tension pneumothorax. Redemonstrated left-sided chest tube has its tip projecting over central left lung zone. 08/25 fungitel interpretation negative result: 31 08/26 PT result 14.6, APTT result: 39.3, INR result 1.30, antiXa unfrac 0.32 08/26 lactic acid result: 2.02 08/26 procalcitonin result: 0.55 08/26 troponin i result: 2.469 08/26 MRSA result: not detected 08/27 SARS-CoV-IgG result: 2.23 08/29 CXR impression: Limited study. Increased moderate pneumomediastinum. ET tube tip about 4.4 cm above the carina. No obvious pneumothorax seen. Extensive airspace disease on the left appears mildly increased. Mild right perihilar infiltrate appears similar 08/30 CXR impression: Slight further increase in pneumomediastinum. 2. More prominent burden of airspace opacities, as above. 3. Tubes and lines as above. 08/31 ABG (ventilator) i-Ph 7.17, I-pco2 47.5, i-Po2 72, iHCO3 17.2, 08/31 FIBRINOGEN result: 161 08/31 DDIMER result: 14.59 08/31 ESR 4 08/31 lactic acid 8.13 08/31 ANTI-XA UFH result: 0.26 08/31 decease
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Endotracheal intubation, Exposure to SARS-CoV-2, Fatigue, Fibrin D dimer, Fungal test negative
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/29, Pfizer, dose #1 (Non-agency) 02/20, Pfizer, dose #2 (Non-agency) 08/03 pt cc: cough, fatigue, headache, dyspnea, severe weakness, chills, diarrhea, exposure: possible wife or daughter 08/06 COVID swab, result: detected 08/06 ED admit dx: covid pna admit to medicine LOS: 2 days 08/12 Another ED admission with direction admission to medicine dx: COVID19 with progressively worsening 08/24 CXR impression: Similar left tension pneumothorax. Redemonstrated left-sided chest tube has its tip projecting over central left lung zone. 08/25 fungitel interpretation negative result: 31 08/26 PT result 14.6, APTT result: 39.3, INR result 1.30, antiXa unfrac 0.32 08/26 lactic acid result: 2.02 08/26 procalcitonin result: 0.55 08/26 troponin i result: 2.469 08/26 MRSA result: not detected 08/27 SARS-CoV-IgG result: 2.23 08/29 CXR impression: Limited study. Increased moderate pneumomediastinum. ET tube tip about 4.4 cm above the carina. No obvious pneumothorax seen. Extensive airspace disease on the left appears mildly increased. Mild right perihilar infiltrate appears similar 08/30 CXR impression: Slight further increase in pneumomediastinum. 2. More prominent burden of airspace opacities, as above. 3. Tubes and lines as above. 08/31 ABG (ventilator) i-Ph 7.17, I-pco2 47.5, i-Po2 72, iHCO3 17.2, 08/31 FIBRINOGEN result: 161 08/31 DDIMER result: 14.59 08/31 ESR 4 08/31 lactic acid 8.13 08/31 ANTI-XA UFH result: 0.26 08/31 decease